Disclosure News
Most Popular Disclosure Story
Would complete disclosure cure the NDA-rejection rash?
John Jenkins, the head of the FDA's Office of New Drugs, has the perfect cure for a chronic rash of poorly conceived new drug applications: Sunshine. And plenty of it, according to a piece in The RPM Read more...
Latest Headlines
- December 10, 2009
- March 25, 2009
- January 12, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
